Trials / Sponsors / Price Vision Group

Price Vision Group

Industry · 10 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Completed	Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection Corneal Endothelial Dystrophy, Corneal Edema	Phase 4	2021-11-23
Recruiting	Corneal Crosslinking for Treatment of Corneal Neovascularization Corneal Neovascularization	Phase 2 / Phase 3	2021-05-03
Terminated	Effect of Xen Implantation on the Aqueous Humor Proteome Primary Open Angle Glaucoma	—	2019-10-24
Completed	Rhopressa for Corneal Edema Associated With Fuchs Dystrophy Fuchs Endothelial Dystrophy	Phase 2 / Phase 3	2019-08-05
Terminated	Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration Fuchs' Endothelial Dystrophy	Phase 2 / Phase 3	2019-07-22
Recruiting	Comparison of Standard vs. Accelerated Corneal Crosslinking Keratoconus, Ectasia Corneal	Phase 2 / Phase 3	2019-04-16
Completed	Effect of TrueTear Corneal Surface Imaging Cataract, Myopia	N/A	2018-08-13
Completed	Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK) Fuchs' Dystrophy, Bullous Keratopathy	Phase 2	2011-10-01
Completed	Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia Keratoconus, Post-Refractive Ectasia	Phase 2	2010-05-01
Terminated	Cross Linking for Treatment of Corneal Infection Infectious Keratitis	N/A	2009-05-01